Kontakt ul. Lwowska 1, 87-100 Toruń
tel.: +48 56 611-25-05
fax: +48 56 611-47-72
e-mail: dwbios@umk.pl

Post-Doctoral Position Announcement within NCN OPUS-21 Project

Zdjęcie ilustracyjne
fot. Nadesłane

Post-Doctoral Position Announcement within NCN OPUS-21 Project

Uniwersytet Mikołaja Kopernika w Toruniu/Nicolaus Copernicus University in Toruń

Earliest Start Date: April 1st, 2023
Funding: 10,000 PLN/month (gross/gross: employer taxes, pension, health insurance and income taxes are deducted from this amount ≈7608 PLN/month [gross: personal income tax and social security deducted from this amount] with 13th month)
Duration: 12month initial contract with possibility to extend an additional 24months.

Candidatures will be evaluated on a rolling basis, until the position is filled.

Project Description: Generation and characterization of synthetic single domain VHH antibodies against nicotinic acetylcholine receptor subtypes. Localization of these subtypes in the brain tissue samples. Under the supervision of the project leader: Dr. Ákos Nemecz. More information about the lab and projects may be found at: nemeczlab.umk.pl


    Ph.D. in biochemistry, pharmacology, biology, or related field.
    (PhD degree must be awarded by another institution than UMK w Toruniu or a continuous post-doctoral fellowship of at least 10 months has been completed, in another country than Poland, prior to hire);
    Ability to work independently on a scientific project including: planning, completing, analyzing experiments as well as the ability to properly present the results;
    Fluent in written and spoken English.

Strongly preferred:

    Experience in protein purification techniques and immunostaining
    Good communication and team working skills

Please send the following application materials to Dr. Ákos Nemecz:

    A cover/motivation letter
    CV, including list of publications/abstracts
    A list of contact information (name, email, position/institution) for three references included in either the CV or cover letter
    A signed GDPR statement: Found here

pozostałe wiadomości